World Vaccine Congress 2025
Syneos Health is a global leader in vaccine development, combining deep scientific expertise, operational excellence and innovative technology to accelerate the path from discovery to delivery. With our Global Vaccine and Emerging Infectious Disease Center of Excellence, we support vaccine developers across the entire asset continuum—from first-in-human through commercialization—leveraging our full-service Phase I-IV capabilities, regulatory expertise and deep understanding of government requirements to navigate complex pathways and aggressive timelines.
Our PredictaVax operating model ensures seamless study execution with real-time analytics, quality oversight and proactive risk mitigation to enhance predictability, efficiency and cost-effectiveness. With a dedicated team of specialists across adult, maternal, pediatric and older populations, we are committed to improving enrollment and retention—meeting over 95% of our vaccine study milestones on time.
Syneos Health brings commercialization and brand strategy expertise to vaccine developers, helping streamline market access and launch planning. Through StudyKIK, a Syneos Health company, we enhance recruitment, retention and patient engagement with digital tools, telemedicine and a network of over 4 million patients worldwide.
Meet with Us
Our team—including experts in clinical operations, regulatory strategy, data analytics and patient access—will be on the ground at the World Vaccine Congress 2025 (Booth #400) to showcase how our end-to-end solutions, global site networks and AI-driven insights can drive faster, more successful vaccine development.
Schedule a time to meet with us and explore how Syneos Health can help you navigate the evolving vaccine landscape.
Featured Sessions
Cracking the Code: Unraveling ePro Challenges in Vaccine Trials
April 22 | 11:40AM ET
Lynlee Burton
Vice President, Project Management, Infectious Diseases and Vaccines
Mitigating the Growing Risk of Duplicate and Professional Participants in Vaccine Clinical trials
April 23 | 9:55AM ET
Lynlee Burton | Vice President, Project Management, Infectious Diseases and Vaccines, Syneos Health
Moderator: Justin Goodarz | Chief Commercial Officer, Verified Clinical Trials
Andrew Cwiertniewicz | Sr. Delivery Director, Fortrea
Navigating Vaccine Trials in Low-and Middle-Income Countries: Challenges and Opportunities
April 23 | 11:40AM ET
Jaime Hernandez, MD, FACP, FIDSA
Executive Medical Director, Clinical Development
Lynlee Burton
Vice President, Project Management, Infectious Diseases and Vaccines
Related Content:
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
